SPIRAL-RT was a Japanese trial that evaluated the safety and efficacy of radiotherapy followed by consolidation durvalumab in patients with LA-NSCLC with PD-L1 expression of ≥25% [17,18]. This evidence concerns the gene CD274 and non-small cell lung carcinoma.